Insider · CIK 0001226877
Sam L Barker
Files at LXRX (LEXICON PHARMACEUTICALS, INC.). First filing -, latest -.
Sam L Barker files SEC Form 4 as director at LXRX (LEXICON PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sam L Barker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +89,312 | $0.00 | $0 | 213,771 | Jun 4, 2026 |
| Jun 3, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -89,312 | $0.00 | $0 | 0 | Jun 4, 2026 |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +35,714 | $0.00 | $0 | 35,714 | May 4, 2026 |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +43,478 | $0.00 | $0 | 43,478 | May 4, 2026 |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +103,806 | $0.00 | $0 | 103,806 | Jun 3, 2025 |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +89,312 | $0.00 | $0 | 89,312 | Jun 3, 2025 |
| May 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +36,810 | $0.00 | $0 | 124,459 | May 13, 2025 |
| May 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -36,810 | $0.00 | $0 | 0 | May 13, 2025 |
Questions about Sam L Barker
Answered from the filings on this page, as of the latest one.
Is Sam L Barker buying or selling?
Sam L Barker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sam L Barker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sam L Barker has 0.
Where does Sam L Barker file Form 4?
Sam L Barker has filed Form 4 at LXRX (LEXICON PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.